Bionano Genomics (BNGO) Short term Debt (2017 - 2023)

Bionano Genomics' Short term Debt history runs 5 years deep, the most recent figure standing at $10.0 million for Q3 2023.

• In Q3 2023, Short term Debt rose 7.49% year-over-year to $10.0 million; the TTM figure through Sep 2023 stood at $10.0 million (up 7.49% YoY), while the FY2022 annual figure was $9.4 million, changed N/A from the prior year.
• Short term Debt came in at $10.0 million for Q3 2023 at Bionano Genomics, roughly flat from $10.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $20.1 million in Q4 2019 to a low of $799815.0 in Q2 2019.
• A 4-year average of $10.4 million and a median of $9.7 million in 2023 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt soared 1642.65% in 2020 and grew 7.49% in 2023, its largest moves.
• Bionano Genomics' Short term Debt stood at $20.1 million in 2019, then dropped by 29.11% to $14.2 million in 2020, then tumbled by 34.11% to $9.4 million in 2022, then increased by 6.59% to $10.0 million in 2023.
• According to Business Quant data, Short term Debt over the past three periods registered $10.0 million, $10.0 million, and $9.5 million for Q3 2023, Q2 2023, and Q1 2023 respectively.

Peer Comparison